Emergency Live - Pre-Hospital Care, Ambulance Services, Fire Safety and Civil Protection Magazine
The innovation could reduce upper-airway bacterial inflammation during intubation, a situation that can lead to chronic inflammation and a condition called subglottic stenosis, the narrowing of the airway by an accumulation of scar tissue.
“We have created a novel device to modulate the upper-airway microbiome, which could be used to prevent bacterial infections during intubation and help prevent subglottic stenosis and other airway diseases,” said senior study author Riccardo Gottardi, PhD, Assistant Professor of Pediatrics and head of the Bioengineering and Biomaterials Laboratory at CHOP.
“Not only does this technology work predictably and continuously over the normal duration of chronically intubated patients, but it is also fast and easy to produce and could easily be modulated to target any bacteria of interest.”
Recent studies have shown that the endotracheal microbiome of intubated patients with subglottic stenosis is unbalanced.
However, addressing the overgrowth of certain bacteria with conventional antibiotics is not ideal, as their use can disrupt the balance of both “good” and “bad” bacteria, while also causing antimicrobial resistance.
Instead, the investigators explored the use of antimicrobial peptides (AMPs), which are small proteins that destabilize bacterial membranes, causing bacterial cells to fall apart and die.
This mechanism of action allows them to target specific bacteria and makes them unlikely to promote antimicrobial resistance.
Prior studies have shown that it is possible to coat endotracheal tubes with conventional antibiotics, so the research team investigated the possibility of incorporating AMPs into polymer-coated tubes to inhibit bacterial growth and modulate the upper-airway microbiome.
The researchers, led by Matthew Aronson, a graduate student in Penn Engineering’s Department of Bioengineering, tested their theory by creating a polymer coating that would release Lasioglossin-III, an AMP with broad-spectrum antibacterial activity.
They found that Lasio released from coated endotracheal tubes, reached the expected effective concentration rapidly and continued to release at the same concentration for a week, which is the typical timeframe that an endotracheal is used before being changed.
The investigators also tested their drug-eluting tube against airway microbes, including S. epidermidis, S. pneumoniae, and human microbiome samples and observed significant antibacterial activity, as well as prevention of bacterial adherence to the tube.
Prehospital Endotracheal Intubation: Elemental Or Detrimental?
Endotracheal Intubation In Paediatric Patients: Devices For The Supraglottic Airways
Children’s Hospital of Philadelphia
Aronson, M.R., et al. (2021) Drug-Eluting Endotracheal Tubes for Preventing Bacterial Inflammation in Subglottic Stenosis. The Laryngoscope. doi.org/10.1002/lary.29769.
Moderna: 'Vaccine efficacy drops by 6% every two months after completing the cycle'
Tourniquet, a study in Los Angeles: 'tourniquet is effective and safe'
Ukraine emergency, the drama of a mother and two children in the words of Porto…
Donbass: Russian Red Cross (RKK) provided psychosocial support to more than 1,300…
Ukraine: the capital Kiev received 12 ambulances and 8 fire and rescue vehicles from…
Ukraine emergency, another cargo ship from the United Arab Emirates with humanitarian…
Ukraine emergency, the drama of a mother and two children in the words of Porto…
Donbass: Russian Red Cross (RKK) provided psychosocial support to more than…
Ukraine: the capital Kiev received 12 ambulances and 8 fire and rescue vehicles…
Ukraine emergency, another cargo ship from the United Arab Emirates with…
War in Ukraine: Red Cross rescuers in Kharkiv, Kharkivska, Uzhhorod and…
Emergency communication, Slovenia also adopts PEMEA standard
The Emergency Service in Georgia will use 41 Piaggio MP3s: the testing phase is…
Caring for the patient...whoever he or she may be: Médecins du Monde (MdM)…
Emd112 donates 30 medical emergency tourniquets to Ukraine
Technological and innovative rescue solutions: MedicalFast at Emergency Expo
Emergency Live is the only multilingual magazine dedicated to people involved in rescue and emergency. As such, it is the ideal medium in terms of speed and cost for trading companies to reach large numbers of target users; for example, all companies involved in some way in the equipping of specialised means of transport. From vehicle manufacturers to companies involved in equipping those vehicles, to any supplier of life- saving and rescue equipment and aids.
Emergency Live Piazzale Badalocchio 9/b, 43126 Parma (PR) – Italy Phone: +39 340 2246247 VAT Number: IT02277610347 Write us: go to the form mail
This website is not intended for the purpose of providing medical advice. All information, content, and material is for information and educational purposes and are not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. All the contents inside this website are addressed to EMS, Rescue and Medical professionals. All the information in the following pages are focused on the health sector, medical devices, pharmaceutical products or products inside these categories, and they request the use of a professional of the health sector.